SlideShare una empresa de Scribd logo
1 de 28
Addressing the growing demand for CNV and UPD detection Dr. Ruth Burton — Product Manager
Today’s agenda
Today’s agenda ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The OGT aCGH design process aCGH arrays All possible human genome probes Oligome TM  database Further selection based on OGT probe rating and desired coverage and content Selection based on specificity, T m , GC, etc. Optimised array design for catalogue and custom products Design & hyb two different aCGH arrays Optimised aCGH design Selection of best performing probes based on experimental results
CytoSure cytogenetics range    high quality data    meaningful results    standardisation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Today’s agenda ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The new CytoSure ISCA UPD array ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],* International Standards for Cytogenomic Arrays (ISCA)
Normal Inheritance What is UPD? father mother
Uniparental disomy (UPD) Heterodisomy Isodisomy
407,787 human SNPs Select most informative SNPs (minor allele frequency of 0.4-0.6) 87,133 SNPs Elect candidate SNPs using OGT probe selection algorithms 19,489 SNPs Step 1: Selecting the SNPs What are the challenges? Microarray Design Analyse to determine functional probe designs
Step 1: Selecting the SNPs What are the challenges? Validation of UPD detection against clinical samples Validation on further set of known genotype samples 6,186 SNPs , each targeted by 2 optimised probes in triplicate, incorporated into 4x180k ISCA aCGH design of  137,100 copy number probes
Allele 1 Allele 2 Step 2: Final design ,[object Object],[object Object],[object Object]
CytoSure Interpret  Software ,[object Object],[object Object],[object Object],[object Object],[object Object],Developing the Software
CytoSure Interpret and UPD — Visualisation Gain Loss
CytoSure Interpret and UPD — Visualisation Gain Loss Genotype Assignment Homozygosity above user-definable threshold Percentage Homozygosity
CytoSure Interpret and UPD — Visualisation Gain Loss Whole Genome Chromosome 6
[object Object],[object Object],[object Object],[object Object],[object Object],CytoSure Interpret and UPD — Analysis
CytoSure Interpret and UPD — Validation ,[object Object],[object Object],
CytoSure Interpret and UPD — Validation ,[object Object],[object Object],[object Object], 
CytoSure Interpret and UPD — Validation ,[object Object],[object Object],[object Object],[object Object],[object Object],  
CytoSure Interpret and UPD — Validation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],  
CytoSure Interpret and UPD — Validation Segmental UPD
CytoSure Interpret and UPD — Validation Segmental UPD
CytoSure Interpret and UPD — Validation Segmental UPD
Today’s agenda ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CytoSure — excellence from sample to result ,[object Object],[object Object],[object Object],[object Object],The complete solution for cytogenetics — arrays (product or custom), software, labelling, reagents, automation, services
Acknowledgements OGT Collaborators and Customers
Thank you www.ogt.co.uk

Más contenido relacionado

La actualidad más candente

Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Matthias Samwald
 
A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers
Thermo Fisher Scientific
 
Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...
Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...
Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...
Thermo Fisher Scientific
 
Oncogenomics july 2012
Oncogenomics july 2012Oncogenomics july 2012
Oncogenomics july 2012
Elsa von Licy
 

La actualidad más candente (20)

Gamida cell ppt_english_5-5-2010
Gamida cell ppt_english_5-5-2010Gamida cell ppt_english_5-5-2010
Gamida cell ppt_english_5-5-2010
 
Oncomine Myeloid GX NGS Solution Infographic
Oncomine Myeloid GX NGS Solution InfographicOncomine Myeloid GX NGS Solution Infographic
Oncomine Myeloid GX NGS Solution Infographic
 
New Technology and Workflow for Integrated Collection, Stabilization and Puri...
New Technology and Workflow for Integrated Collection, Stabilization and Puri...New Technology and Workflow for Integrated Collection, Stabilization and Puri...
New Technology and Workflow for Integrated Collection, Stabilization and Puri...
 
Visualizing Human Stem Cell Dynamics by Multicolor, Multiday High-Content Mic...
Visualizing Human Stem Cell Dynamics by Multicolor, Multiday High-Content Mic...Visualizing Human Stem Cell Dynamics by Multicolor, Multiday High-Content Mic...
Visualizing Human Stem Cell Dynamics by Multicolor, Multiday High-Content Mic...
 
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
 
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
 
A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers
 
Samwald cshals2013
Samwald cshals2013Samwald cshals2013
Samwald cshals2013
 
Utsw 2020 1
Utsw 2020 1Utsw 2020 1
Utsw 2020 1
 
Nous reptes de la Medicina de Precisió
Nous reptes de la Medicina de PrecisióNous reptes de la Medicina de Precisió
Nous reptes de la Medicina de Precisió
 
Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...
Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...
Developing Custom Next-Generation Sequencing Panels using Pre-Optimized Assay...
 
Sequencing and functional genomics Unit_Biomedical Research Center of Aragon_...
Sequencing and functional genomics Unit_Biomedical Research Center of Aragon_...Sequencing and functional genomics Unit_Biomedical Research Center of Aragon_...
Sequencing and functional genomics Unit_Biomedical Research Center of Aragon_...
 
Oncogenomics july 2012
Oncogenomics july 2012Oncogenomics july 2012
Oncogenomics july 2012
 
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
 
Validation of Identity and Ancestry SNP Panels for the Ion PGM™ System
Validation of Identity and Ancestry SNP Panels for the Ion PGM™ SystemValidation of Identity and Ancestry SNP Panels for the Ion PGM™ System
Validation of Identity and Ancestry SNP Panels for the Ion PGM™ System
 
A high-throughput approach for multi-omic testing for prostate cancer research
A high-throughput approach for multi-omic testing for prostate cancer researchA high-throughput approach for multi-omic testing for prostate cancer research
A high-throughput approach for multi-omic testing for prostate cancer research
 
mHealth Israel_Ryo Kosaka_AIST_National Institute of Advanced Industrial Scie...
mHealth Israel_Ryo Kosaka_AIST_National Institute of Advanced Industrial Scie...mHealth Israel_Ryo Kosaka_AIST_National Institute of Advanced Industrial Scie...
mHealth Israel_Ryo Kosaka_AIST_National Institute of Advanced Industrial Scie...
 
FFPE Applications Solutions brochure
FFPE Applications Solutions brochureFFPE Applications Solutions brochure
FFPE Applications Solutions brochure
 
Epigenetics 2013
Epigenetics 2013Epigenetics 2013
Epigenetics 2013
 
高雄醫師會誌94期-醫學專欄~陳俊廷-淺談藥物性肝炎
高雄醫師會誌94期-醫學專欄~陳俊廷-淺談藥物性肝炎高雄醫師會誌94期-醫學專欄~陳俊廷-淺談藥物性肝炎
高雄醫師會誌94期-醫學專欄~陳俊廷-淺談藥物性肝炎
 

Similar a Addressing the growing demand for CNV and UPD detection

Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
sequencing_columbia
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Integrated DNA Technologies
 
Cnv and a analysis strategies
Cnv and a analysis strategiesCnv and a analysis strategies
Cnv and a analysis strategies
Elsa von Licy
 
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practiceAug2013 Heidi Rehm integrating large scale sequencing into clinical practice
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
GenomeInABottle
 
2012 10-24 - ngs webinar
2012 10-24 - ngs webinar2012 10-24 - ngs webinar
2012 10-24 - ngs webinar
Elsa von Licy
 
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Intel IT Center
 

Similar a Addressing the growing demand for CNV and UPD detection (20)

Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
 
2017 molecular profiling_wim_vancriekinge
2017 molecular profiling_wim_vancriekinge2017 molecular profiling_wim_vancriekinge
2017 molecular profiling_wim_vancriekinge
 
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
Peter Nagy, Columbia Agilent Symposium, Jan, 27 2012
 
Axt microarrays
Axt microarraysAxt microarrays
Axt microarrays
 
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
 
Ngs webinar 2013
Ngs webinar 2013Ngs webinar 2013
Ngs webinar 2013
 
Ashg presentation 2010
Ashg presentation 2010Ashg presentation 2010
Ashg presentation 2010
 
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
 
Oncogenomics 2013
Oncogenomics 2013Oncogenomics 2013
Oncogenomics 2013
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
 
Cnv and a analysis strategies
Cnv and a analysis strategiesCnv and a analysis strategies
Cnv and a analysis strategies
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practiceAug2013 Heidi Rehm integrating large scale sequencing into clinical practice
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
 
2012 10-24 - ngs webinar
2012 10-24 - ngs webinar2012 10-24 - ngs webinar
2012 10-24 - ngs webinar
 
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-enPp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
 
High Through-Put DNA Methylation Analysis of Lung Cancer: Plasma cfDNA for Bi...
High Through-Put DNA Methylation Analysis of Lung Cancer: Plasma cfDNA for Bi...High Through-Put DNA Methylation Analysis of Lung Cancer: Plasma cfDNA for Bi...
High Through-Put DNA Methylation Analysis of Lung Cancer: Plasma cfDNA for Bi...
 
Massively Parallel Sequencing - integrating the Ion PGM™ sequencer into your ...
Massively Parallel Sequencing - integrating the Ion PGM™ sequencer into your ...Massively Parallel Sequencing - integrating the Ion PGM™ sequencer into your ...
Massively Parallel Sequencing - integrating the Ion PGM™ sequencer into your ...
 
New Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overviewNew Generation Sequencing Technologies: an overview
New Generation Sequencing Technologies: an overview
 
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
Developing tools & Methodologies for the NExt Generation of Genomics & Bio In...
 

Último

Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
Joaquim Jorge
 

Último (20)

Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
Understanding Discord NSFW Servers A Guide for Responsible Users.pdf
Understanding Discord NSFW Servers A Guide for Responsible Users.pdfUnderstanding Discord NSFW Servers A Guide for Responsible Users.pdf
Understanding Discord NSFW Servers A Guide for Responsible Users.pdf
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Advantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your BusinessAdvantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your Business
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdf
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 

Addressing the growing demand for CNV and UPD detection

  • 1. Addressing the growing demand for CNV and UPD detection Dr. Ruth Burton — Product Manager
  • 3.
  • 4. The OGT aCGH design process aCGH arrays All possible human genome probes Oligome TM database Further selection based on OGT probe rating and desired coverage and content Selection based on specificity, T m , GC, etc. Optimised array design for catalogue and custom products Design & hyb two different aCGH arrays Optimised aCGH design Selection of best performing probes based on experimental results
  • 5.
  • 6.
  • 7.
  • 8. Normal Inheritance What is UPD? father mother
  • 9. Uniparental disomy (UPD) Heterodisomy Isodisomy
  • 10. 407,787 human SNPs Select most informative SNPs (minor allele frequency of 0.4-0.6) 87,133 SNPs Elect candidate SNPs using OGT probe selection algorithms 19,489 SNPs Step 1: Selecting the SNPs What are the challenges? Microarray Design Analyse to determine functional probe designs
  • 11. Step 1: Selecting the SNPs What are the challenges? Validation of UPD detection against clinical samples Validation on further set of known genotype samples 6,186 SNPs , each targeted by 2 optimised probes in triplicate, incorporated into 4x180k ISCA aCGH design of 137,100 copy number probes
  • 12.
  • 13.
  • 14. CytoSure Interpret and UPD — Visualisation Gain Loss
  • 15. CytoSure Interpret and UPD — Visualisation Gain Loss Genotype Assignment Homozygosity above user-definable threshold Percentage Homozygosity
  • 16. CytoSure Interpret and UPD — Visualisation Gain Loss Whole Genome Chromosome 6
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22. CytoSure Interpret and UPD — Validation Segmental UPD
  • 23. CytoSure Interpret and UPD — Validation Segmental UPD
  • 24. CytoSure Interpret and UPD — Validation Segmental UPD
  • 25.
  • 26.

Notas del editor

  1. ISCA developed with the ISCA steering committee. Optimised by OGT. Several groups have appreciated the cleaner calls and better coverage and have switched to the CytoSure platform. OGT is the exclusive distributor of the SciGene range of automated products for aCGH. Initially when labs move into using arrays they start using a manual approach. Our experience has shown that many labs quickly ramp up their sample numbers so automation becomes an important consideration. Having automation can also standardise results. Interestingly, OGT uses some of the Scigene products in its HT service facility. For example the Little Dipper for array washing and drying – also useful in FISH and GBanding. We have a Little Dipper on the booth this week if youd like to come and have a look.
  2. Results Figure 1: Figure showing the SNP selection and probe design validation process used to identify probes capable of discriminating between SNP alleles
  3. Results Figure 1: Figure showing the SNP selection and probe design validation process used to identify probes capable of discriminating between SNP alleles
  4. General outsourced services: CRUK, ICR Custom aCGH services: UVA,, Leuven, Wessex, Sanger, UCSD, CSHL Custom aCGH products: Karolinska, Emory, Greenwood Custom Methylation Services: Greenwood